HiberCell
Feven Tameire, Ph.D., is a passionate cancer biologist with an expertise in stress response signaling pathways that are critical for tumor progression. During her doctorate years, Feven received several scientific awards including a predoctoral fellowship from National Institutes of Health (NIH). She has 10 publications in the areas of cancer biology, integrated stress response and oncogene-induced stress response.
Feven received a B.A. in biology from University of Virginia and a Ph.D. in cell and molecular biology from the University of Pennsylvania.
This person is not in any offices
HiberCell
2 followers
Despite significant advances in treatment of primary tumors, metastatic cancer remains a leading cause of solid cancer mortality. HiberCell seeks to change that. As “the dormancy company,” they are the first company exclusively focused on therapeutically modulating the biology and mechanisms of tumor dormancy.